Home > Current issue > JPPR 2011 > JPPR September 2011

Volume 41, No. 3, September 2011


Marketing Pharmaceuticals: Are the Benefits Real?
Ian Larmour, 172

Rethinking Healthcare Leadership
Miles F Shore, Eleanor G Shore, 175

Clinical Pharmacy Education in the Middle East and Asia: Are we Doing it Right?
Mohamed Izham M Ibrahim, 176

Entangling Experts
John S Dowden, 179


External Surface Contamination of Cytotoxic Admixtures: Caveat Emptor * (members only)abstract
Jim Siderov, Sue Kirsa, Robert McLauchlan, 181

Bayesian Optimisation of Tobramycin Dosing in Paediatric Patients with Cystic Fibrosis (members only) abstract
Michael Barras, Hana Alraman, Carl MJ Kirkpatrick, Margaret Harris, Carolyn Dakin, Katrina Jess, Melissa Pilbeam, Ross LG Norris, 183

Non-Therapeutic Medication Omissions: Incidence and Predictors at an Australian Hospital (members only) abstract
Sharon L Latimer, Wendy Chaboyer, Tony Hall, 188

Smart Infusion Pumps Reduce Intravenous Medication Administration Errors at an Australian Teaching Hospital * (members only) abstract
Rebecca KY Pang, David CM Kong, Jan-Marie deClifford, Skip S Lam, Benjamin K Leung, 192

Direct–to–Consumer Advertising of Prescription Medicines on the Internet: An Australian Consumer Perspective * (members only) abstract
Phoebe Gu, Kylie A Williams, Parisa Aslani, Betty B Chaar, 196

Post-Registration Learning Trends of Community Pharmacists (members only) abstract
Rhonda M Clifford, Pretisha L Ram, Anneika Lakos, Sajni Gudka, Liza J Seubert, Carl R Schneider, Lesley AH Gregory, 203

Successful Implementation of a Pharmacist Anticoagulant Dosing Service in Ambulatory Care (members only) abstract
Michael J Dooley, Josephine V McGuiness, Shin Choo, Lam-Lan Ngo-Thai, Erica Tong, Katrina Neave, Susan Poole, Alison Street, 208

Impact of a Surgical Preadmission Clinic Pharmacist on the Quality of Medication Management from Preadmission to Discharge: a Randomised Controlled Study (members only) abstract
Lewis JW George, Reyhan Senturk-Raif, Marisa R Hodgkinson, Maggie Emmerton, Ian Larmour, 212

Dexamethasone Use in Inpatient Palliative Care (members only) abstract
Mona Kiani, Anna YM Yip, Penelope HR Tuffin, Malcolm Roberts, Rhonda M Clifford, 217

Revisiting Guidelines and Inappropriate use of Ticarcillin/Clavulanate at an Australian Teaching Hospital (members only) abstract
Tina H Patterson, Sean Unwin, David FM Looke, Peter I Pillans, Lynette M Loy, 221

Case Report

Systemic Absorption from Oral Vancomycin: Check the Dose! (members only) abstract
John Coutsouvelis, Kate A Witney, Carmela E Corallo, Denis Spelman, 225

Medication Safety

Medication Safety Series
Edited by Penny Thornton, 227

Geriatric Therapeutics

Drugs, Delirium and Older People *
Mary E Britton, 233


DrugScan Series (members only)
Edited by Vaughn Eaton, 239

Other Sections

Letter to the Editor

Medicines spending trends in a Malaysian public hospital. Chan Bee Leng, Mohamed Izham M Ibrahim, Asrul A Shafie, Salmah Bahri, 250

Erratum: Seleem M, et al.  (Managing patients on antiplatelet drugs requiring emergency non-cardiac surgery. (members only) J Pharm Pract Res 2011; 41: 132-4.), 187
SHPA CPD Articles, 181, 192, 196, 233
SHPA Research and Development Grants Program, 179, 207
Advertisers’ Index, 250


Article Reprints

Copies of articles from the Journal of Pharmacy Practice and Research and The Australian Journal of Hospital Pharmacy can be ordered from the National Library of Australia. You can order online at the NLA website by providing the citation and credit card details.

Member Login

Forgotten your login details?

Join SHPA.
Buy online courses

  • Update on Medicinal Cannabis
  • As medicinal cannabis products become more accessible and prescribed, hospital pharmacists will need to be cognisant of how these medicines are handled and the federal and jurisdictional requirements they will need to comply with. SHPA is committed to keeping abreast of this emerging therapy, and below is a snapshot on where medicinal cannabis is at presently in Australia.
  • SHPA Will Take Action to Support Continuation of Advanced Practice Recognition
  • The Society of Hospital Pharmacists of Australia (SHPA) CEO, Kristin Michaels, responding to today's announcement by the Australian Pharmacy Council to end the National Credentialing of Advanced Practice Pharmacists, said the Society will continue to strongly support Advanced Practice.
  • SHPA Vision for the Future of Pharmacy is Winning Strong Support
  • Professor Michael Dooley said today the Society has received over 30 applications from hospitals and health services for the SHPA Residency Program inaugural intake commencing in 2017.


    Member Login


    Logging Into SHPA Website.